MX2011011561A - Vacunas novedosas contra el virus de la influenza pandemica a/h1n1. - Google Patents

Vacunas novedosas contra el virus de la influenza pandemica a/h1n1.

Info

Publication number
MX2011011561A
MX2011011561A MX2011011561A MX2011011561A MX2011011561A MX 2011011561 A MX2011011561 A MX 2011011561A MX 2011011561 A MX2011011561 A MX 2011011561A MX 2011011561 A MX2011011561 A MX 2011011561A MX 2011011561 A MX2011011561 A MX 2011011561A
Authority
MX
Mexico
Prior art keywords
vaccines against
flu virus
virus
novel vaccines
pandemic flu
Prior art date
Application number
MX2011011561A
Other languages
English (en)
Inventor
Manuel Zepeda Lopez Hector
Original Assignee
Inmunolife S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunolife S A De C V filed Critical Inmunolife S A De C V
Priority to MX2011011561A priority Critical patent/MX2011011561A/es
Priority to CA2826234A priority patent/CA2826234A1/en
Priority to KR1020137014167A priority patent/KR20130140050A/ko
Priority to EP11838278.7A priority patent/EP2650362A4/en
Priority to AP2013006835A priority patent/AP2013006835A0/xx
Priority to BR112013010830A priority patent/BR112013010830A2/pt
Priority to PCT/MX2011/000132 priority patent/WO2012060678A2/es
Priority to CN2011800639058A priority patent/CN103328629A/zh
Priority to EA201300525A priority patent/EA201300525A1/ru
Priority to JP2013537626A priority patent/JP2014511119A/ja
Publication of MX2011011561A publication Critical patent/MX2011011561A/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención se refiere a vacunas contra el virus de influenza, en particular a un virus de influenza en la que al menos, el gen de hemaglutinina contiene una mutación D222, y un gen de neruaminidasa resistente al oseltamivir. En algunas de las implementaciones en particular, la vacuna del virus de influenza comprende además una mutación que incrementa la respuesta inmune específica en humanos. El virus es útil para la producción de vacunas contra la influenza resistente al oseltamivir e hipervirulenta.
MX2011011561A 2010-11-02 2011-10-31 Vacunas novedosas contra el virus de la influenza pandemica a/h1n1. MX2011011561A (es)

Priority Applications (10)

Application Number Priority Date Filing Date Title
MX2011011561A MX2011011561A (es) 2011-10-31 2011-10-31 Vacunas novedosas contra el virus de la influenza pandemica a/h1n1.
CA2826234A CA2826234A1 (en) 2010-11-02 2011-11-01 Novel vaccines against the a/h1n1 pandemic flu virus
KR1020137014167A KR20130140050A (ko) 2010-11-02 2011-11-01 Ａ/ｈ1ｎ1 범유행 인플루엔자 바이러스에 대한 신규한 백신
EP11838278.7A EP2650362A4 (en) 2010-11-02 2011-11-01 NEW VACCINES AGAINST PANDEMIC INFLUENZA A / H1N1 VIRUS
AP2013006835A AP2013006835A0 (en) 2010-11-02 2011-11-01 Novel vaccines against the A/H1N1 pandemic flu virus
BR112013010830A BR112013010830A2 (pt) 2010-11-02 2011-11-01 vacina inovadoras contra o vírus da influenza pandêmica a/h1n1
PCT/MX2011/000132 WO2012060678A2 (es) 2010-11-02 2011-11-01 Vacunas novedosas contra el virus de la influencia pandémica a/h1n1
CN2011800639058A CN103328629A (zh) 2010-11-02 2011-11-01 针对大流行性甲型流感病毒h1n1的新型疫苗
EA201300525A EA201300525A1 (ru) 2010-11-02 2011-11-01 Новые вакцины против пандемичного вируса гриппа a/h1n1
JP2013537626A JP2014511119A (ja) 2010-11-02 2011-11-01 Ｈ１ｎ１亜型インフルエンザパンデミックウイルスに対する新型ワクチン

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011011561A MX2011011561A (es) 2011-10-31 2011-10-31 Vacunas novedosas contra el virus de la influenza pandemica a/h1n1.

Publications (1)

Publication Number Publication Date
MX2011011561A true MX2011011561A (es) 2017-12-06

Family

ID=60996777

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011561A MX2011011561A (es) 2010-11-02 2011-10-31 Vacunas novedosas contra el virus de la influenza pandemica a/h1n1.

Country Status (1)

Country Link
MX (1) MX2011011561A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2735291C1 (ru) * 2019-12-17 2020-10-29 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Вакцинный штамм вируса гриппа А/17/БРИСБЕН/2018/8175 (H1N1) pdm09 для производства живой гриппозной интраназальной вакцины для взрослых и для детей

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2735291C1 (ru) * 2019-12-17 2020-10-29 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Вакцинный штамм вируса гриппа А/17/БРИСБЕН/2018/8175 (H1N1) pdm09 для производства живой гриппозной интраназальной вакцины для взрослых и для детей

Similar Documents

Publication Publication Date Title
WO2012060678A3 (es) Vacunas novedosas contra el virus de la influencia pandémica a/h1n1
NZ627796A (en) Influenza virus vaccines and uses thereof
IL262123A (en) Influenza virus vaccines and their uses
WO2010077986A3 (en) Production of influenza vaccines
HK1199211A1 (en) Influenza virus vaccines and uses thereof
HK1203524A1 (en) Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses h3n2h2n2 b
HK1203522A1 (en) Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses h5n1 h1n1
EP2758038A4 (en) NEW INFLUENZA HEMAGGLUTININ PROTEIN VACCINES
EA201290897A1 (ru) Вакцины для пандемического гриппа
PL408649A1 (pl) Białko hemaglutyniny wirusów grypy jako antygen szczepionkowy
EA201590860A1 (ru) Варианты гемагглютинина и нейраминидазы вируса свиного гриппа
MX363464B (es) Vacunas contra influenza h5.
AU2015364253B2 (en) Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza
EP3599247A3 (en) Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
FR2962739B1 (fr) Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza
MX2011011561A (es) Vacunas novedosas contra el virus de la influenza pandemica a/h1n1.
WO2012061239A3 (en) Novel vaccines against pandemic influenza virus a/h1n1
EP2636735A4 (en) RECOMBINANT VACCINIA VIRUS WITH HEMAGGLUTININE PROTEINS DERIVED FROM NEW INFLUENZA VIRUSES
SG11201403773WA (en) Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3
SG10201601365RA (en) Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use
MY180091A (en) Vaccines and vaccine compositions, and methods for the manufacture thereof
MX360137B (es) Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento.
WO2011138032A3 (en) Universal influenza vaccines and methods for their generation
PL406631A1 (pl) Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie
GB2547494A (en) Monovalent H5 vaccine

Legal Events

Date Code Title Description
GB Transfer or assignment

Owner name: INMUNOLIFE, S.A. DE C.V.